Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Clinical trial NCT00970203 · COMPLETED

Trial details

NCT number: NCT00970203
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer of Prostate Cancer of the Prostate Neoplasms, Prostate Neoplasms, Prostatic Prostate Cancer Prostate Neoplasms Prostatic Cancer

Start date: 2009-09-01
Primary completion: 2018-10-05
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.